Search results for: "Novo Nordisk" (167 records) Manufacturing Novo Nordisk donates $40m wastewater pre-treatment facility The pre-treatment plant will serve Novo Nordisk’s new $2bn API manufacturing facility, but will be able to treat almost 450,000 gallons a day to serve other pharma facilities... Research & Development Novo Nordisk funds $27m global biomanufacturing programme The five-year research and training project will be run as a collaborative effort between North Carolina State University and the Technical University of Denmark Finance Purdue Pharma sells North Carolina site to Novo Nordisk The solid dose manufacturing site will be refurbished to manufacture tablets for oral semaglutide (diabetes treatment) and future oral medicines Manufacturing Novo Nordisk expands Danish production facilities Almost US$100 million will be spent in Danish production sites to upgrade facilities to manufacture next generation diabetes treatment products Finance Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement with DKSH The Danish pharma company and the Swiss market expansion expert have partnered to provide high-quality cGMP quaternary ammonium compounds in eleven markets across the region Media Bristol diabetes spin-out company acquired by Novo Nordisk The global healthcare company has acquired all of the shares of the Bristol supramolecular chemistry company, of which total payments under the agreement could ultimately... Ingredients Novo Nordisk enters a distribution agreement with Signet Chemical The deal will enable customers in India, Bangladesh and Sri Lanka to access Novo Nordisk's range of FEF Quats Media GlobalData publishes analysis of top 25 global pharma companies The data and analytics company has tracked the market cap performance of the top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number... Research & Development Semaglutide shows reductions in blood sugar and weight Semaglutide demonstrated significant reductions in blood sugar and weight compared with dulaglutide Election of employee representatives to board of Novo Nordisk Regulatory Novo Nordisk seeks regulatory approval Novo Nordisk files for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A Media GlobalData names top 25 global pharma companies by market cap The performance highlights of the top 25 publicly traded global pharma companies for the year 2017 have been confirmed in the latest research from GlobalData Media Steep rise in type 2 diabetes in South-East Asia The latest report “Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 — Increasing Usage of Newer Therapies and Expanding Treatment Population to... Manufacturing Novo Nordisk Pharmatech to exhibit at CPhI Worldwide 2017 Delivering excellence at every step Novo Nordisk Pharmatech is a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries Distribution Novo Nordisk enters distribution agreement for quats Novo Nordisk Pharmatech enters distribution agreement with Azelis for pharmaceutical grade quaternary ammonium compounds Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the... Previous1234 (current)567…11Next